Biologics US 2024

03 - 04 October 2024 | San Diego, CA

Driving the discovery & development of safe, effective & innovative biologic drugs through streamlined discovery, clinical and analytical strategies

Event Page - Hero Banner 2
Overview Proteins & Antibodies Peptides ADC Discovery & Development

Explore Biologics US 2024: Overcoming the Complexities of Biologics Development

Biologics have come to the forefront of the pharmaceutical industry, with ever-increasing demand for large molecule products, but their development still presents unique and complex challenges from both technical and regulatory perspectives. Join 550+ leaders from across the US biologics industry at Biologics US to discuss the innovative strategies & technologies needed to enable more effective biological products to enter the market. 

Across two days, it features novel case studies from all corners of the biologics industry, with dedicated programmes covering next-generation Protein & Antibody Therapeutics, Peptides, and Antibody-Drug Conjugates. Alongside innovative presentations, our curated programme allows for in-depth networking – fostering new partnerships that will advance your pipeline and help you translate your innovative target from bench to bedside.

Proteins & Antibodies US Congress 2024

From new engineering technologies and AI/ML-guided approaches through to novel analytical development methods and success stories in NextGen therapeutics, the Proteins & Antibodies US Congress provides an all-encompassing look at the back-bone of the biologics industry.

Agenda at a Glance

Day One | Track 1: Antibody Discovery & Engineering

Day One | Track 2: Bioanalytical Development

Day Two | Track 1: Computational Tools, AI/ML-Guided Engineering

Day Two | Track 2: NextGen Therapeutics – Multispecifics, Cell Engagers, & Other New Modalities

Peptides US Congress 2024

Peptide drug development has made huge progress in the last decade, with advancements in production, modification and analytical technologies. With this rise in investment and innovation continuing to increase, our dedicated Peptides Congress showcases novel data in peptide CMC, delivery and drug development, supporting you as you look to optimize complex molecules.

Agenda at a Glance

Day One | Track 3: Peptide Discovery & Development

Day Two | Track 3: Peptide Formulation, Delivery & Manufacturing

ADC Discovery & Development US Congress

2023 proved to be a monumental year for the ADCs industry, with high-profile collaborations between biopharma organizations and innovative new molecules reaching the clinic. The ADC Discovery & Development Congress seeks to advance ADC development further by maximizing efficiency and minimizing toxicity through safe, effective and streamline preclinical, clinical and CMC strategies. Further sessions look at the next-generation of conjugates, showcasing new approaches that could tackle different disease areas where there is currently unmet need.

Agenda at a Glance

Day One | Track 4: Engineering Conjugates to Enhance Therapeutic Potential

Day One | Track 5: Advancing Analytical Methods

Day Two | Track 4: Translational & Clinical Lessons

Day Two | Track 5: Manufacturing, CMC & Process Development 

What to Expect


leading pharma, biotech & academic delegates

hours of presentations, discussions & interactive content
hours of networking breaks, including speed networking & refreshments
hours of pre-arranged 1-2-1 meetings, facilitating business growth
Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 120 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Companies Represented Include

Meet Our Expert Speakers

Biologics US 2024 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Below are some of our featured speakers:

Amita Datta-Mannan
Associate Vice President, Exploratory Medicine and Pharmacology,
Eli Lilly & Company
Brittney Mills
Associate Director,
Hans van der Vliet
LAVA Therapeutics
Lauren Goodrich
VP, Therapeutic Discovery,
Nimble Therapeutics
Matt Chu
Astellas Pharma US
Natalie Grinshtein
Director, ADC discovery,
Nazneen Dewji
President and Chief Executive Officer,
Cenna Biosciences
Olivier Kitten
Founder and Chief Executive Officer,
Robert Lutz
Iksuda Therapeutics
Suk Hyung
Senior Principal Scientist,
Yi Xing
Senior Director,
Seismic Therapeutic
Alan Wahl
Aming Zhang
Head of AD and QC,
Pyxis Oncology
Andrew Vendel
Senior Director, Immunology,
Eli Lilly
Brandon Coyle
Associate director,
Gilead Sciences
Brian Avanzino
Principal Scientist,
Brian Hall
Distinguished Scientist,
Christopher Hart
Chief Executive Officer,
Creyon Bio
Daniel Kirchhofer
Senior Fellow,
Genentech Inc.
Jack Ostrowski
Director Protein Science,
Avidity Biosciences
Jan Schnitzer
Chief Executive Officer & President,
Jay Jones
Jean Ge
Patent Attorney,
Wolf Greenfield
Jeffrey Leyton
Associate Professor,
University of Ottawa
Jianzhong Wen
Senior Principal Scientist,
Merck & Co. Inc,
Julie Beaudet
CMC Sr. Staff Scientist,
Regeneron Pharmaceuticals
Kim Janda
The Scripps Research Institute
Leonard Reyno
Executive Vice President & Chief Medical Officer,
C4 Therapeutics
Li Feng
Lian Yi
Principal Scientist,
Linda Horner
Chief Administrative Patent Judge,
United States Patent and Trademark Office
Madhura Deshpande
Principal Scientist,
Bristol Myers Squibb
Maria Hedlund
Principal Scientist, Toxicology,
Avidity Biosciences
Melissa Schutten
Senior Director,
Michael Cochran
Director, Chemistry,
Avidity Biosciences
Michael McPherson
Research Fellow,
Michael Sierks
Arizona State University
Mike Schopperle
Mimmi Ballard
Director, ADQC, Bioassays,
Vir Biotechnology
Nathan Alves
Associate Professor / Director of Translational Research,
Indiana University School of Medicine
Philip Kim
University of Toronto
Purbasa Patnaik
Associate Director,
Rajika Perera
Poseidon LLC
Ramana Doppalapudi
Vice President, Chemistry,
Avidity Biosciences
Sasha Ebrahimi
Principal Investigator and Associate Fellow,
Steven Ballet
Professor, Departments of Chemistry and Bio-Engineering Sciences,
Free University Brussels
Sylvia Yip
Intellectual Property Counsel,
Zentalis Pharmaceuticals
Udaya Rangaswamy
Director, Translational Biology,
Rondo Therapeutics
Umer Hassan
Associate Professor,
Rutgers University
Wei Wang
UC San Diego Health
Yang Su
Principal Scientist,
Bristol Myers Squibb
Yuan Cheng
Director of Hybrid Modality,

Interested in Sponsoring?

Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

Learn more

Latest Resources

FDA Fast Track ADC for Patients with Triple Negative Breast Cancer

The fast track designation means that the clinical development and regulatory milestones of the drug candidate are likely to progress much faster.

GSK Buys CureVac's mRNA Vaccine Business Providing Welcome Cash Injection

CureVac will continue to build its R&D pipeline while allowing GSK to develop and commercialise a handful of its prophylactic mRNA vaccines.

2002 Nobel Prize for Chemistry: Kurt Wüthrich, Using NMR to Determine the 3D Structure of Proteins

Kurt Wüthrich, joint winner of the 2002 Nobel Prize for Chemistry, contributed to the use of NMR to discover the 3D structure of proteins using sequential assignment and mathematical techniques.

Looking Back on the 2002 Nobel Prize for Chemistry: Mass Spectrometry for the Analysis of Proteins

2002's Nobel Prize for Chemistry recognised the translation of mass spectrometry to large molecules which has been instrumental in unlocking the proteome toward new therapies.

H5N1 Bird Flu Outbreaks: Effect on Vaccines

H5N1 outbreaks in the US have mobilised pandemic preparedness mechanisms with stockpiling of avian flu vaccines.

"World's First" IND Approval for Epstein-Barr mRNA Cancer Vaccine

Epstein-Barr virus has been highly linked to over ten forms of cancer. This wide range of malignant implications means an expanded variety of target indications for the vaccine.

Plan Your Visit

The Westin San Diego Gaslamp Quarter

910 Broadway Circle

San Diego, 92101


United States

The Westin San Diego Gaslamp Quarter sits in the heart of the city's excitement, located near the Gaslamp quarter home to over 150 restaurants, cafes, bars, and shops. The Westin is also steps away from the San Diego Convention centre, Little Italy and Pecto Park. Within a 10 minute drive, you can also explore nearby beaches and attractions at the San Diego Zoo, Mission Beach's Belmont Park and SeaWorld San Diego.


By Air:
San Diego International Airport – The Westin San Diego Gaslamp Quarter is approximately 2 miles from the international airport. A taxi to and from the airport would cost around $12 - $15 and would take around 5-10 minutes depending on traffic.

The Westin San Diego offers airport transportation from 5am-11pm – please contact the hotel directly for more information about this.


By Train:
The closest train station to the venue is Santa Fe Depot which is roughly a 10-minute walk away. The North Country Transit is approximately a 10 min drive away. Please use the directions from the train station to direct yourself to the hotel.


By Bus: 
The closest bus station to the hotel are Broadway & Union St and Broadway & 2nd Av which are a 2 min walk away.


Parking is available at the hotel, with electric car charging stations at a daily parking valet of $60.00. Underground parking valet only USD 10 per hour or USD 60 overnight. Please note the garage height clearance is 8 feet. Please visit the hotel’s website for more information.

Oxford Global has secured a number of bedrooms at the The Westin San Diego Gaslamp Quarter at a reduced conference rate: 


  • Wednesday 2nd October 2024 – $315 (includes room rate & taxes)
  • Thursday 3rd October 2024 – $315 (includes room rate & taxes)


Should you wish to book a room, please click here 


The final cut-off date to book bedrooms is Wednesday 11th September 2024 – any bookings after this date are subject to availability and rates. Please note, that any cancellations within 14 days prior to arrival are subject to cancellation charges.


Additionally, we kindly remind all attendees to only book their accommodation if they are registered for the event. This ensures that accommodations are available for those who have officially secured their attendance.

We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.

As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.

Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.

Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.

If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Biologics US 2024 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.

Register Your Interest

Submit your details and a member of our team will be in touch